If companies were allowed to fund HRAs for the purpose of allowing workers to buy their own insurance, some companies might do it, research suggests.
However, employers' disdain for several aspects of the law, and their wish for changes to it, remain intact.
The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
Employers expect to cut way back next year on shifting health costs to their workers.
While millions would become uninsured if the bill became law, group health plans would mostly benefit, observers say.
Consumer-directed health plans may not become as ubiquitous as once thought, survey results suggest.
Standard approaches to measuring returns on wellness initiatives are worthless, as the analysis must be customized to a company's particular needs.
Proactive health-care organizations are focusing big data and analytics efforts on transforming both delivery and costs.
While the medical inflation rate is still twice that of general inflation, an evolution in pricing and delivery models could ultimately change the…
As core strategies for containing employee health-care costs diminish in effectiveness, companies need fresher approaches.